Latest Cancer News

Biomarker Analysis Identifies Women Most Likely to Benefit From Kadcyla (05-20-2013)
Among women with metastatic, HER2-positive breast cancer, those with the highest tumor HER2 levels benefit the most from the drug Kadcyla™ (ado-trastuzumab emtansine, formerly known as T-DM1), according... Continue Reading

Novel Two-step Immunotherapy Shows Promise in Recurrent Ovarian Cancer (05-17-2013)
A novel two-step immunotherapy approach yielded clinically beneficial responses in patients with advanced ovarian cancer, according to data from two phase I clinical trials presented at the American Association... Continue Reading

Following Lifestyle Recommendations Reduces Risk of Cancer Death (05-15-2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading

More Cancer News

Patient Resources